Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
IV
117TH CONGRESS
1ST SESSION
H. RES. 424
Expressing support for the designation of June 1, 2021, as ‘‘Batten Disease
Awareness Day’’.
IN THE HOUSE OF REPRESENTATIVES
MAY 20, 2021
Mr. GARCIA of California submitted the following resolution; which was
referred to the Committee on Energy and Commerce
RESOLUTION
Expressing support for the designation of June 1, 2021,
as ‘‘Batten Disease Awareness Day’’.
Whereas Batten disease is a family of rare genetic disorders
of the nervous system that typically begins in childhood;
Whereas there are many forms of Batten disease, and the
mutations of at least 14 different genes are known to
cause the disease;
Whereas symptoms of the fatal disease include vision loss
leading to blindness, personality and behavioral changes,
seizures, intellectual decline, disruption and loss of
speech, dementia, and other debilitating ailments;
Whereas depending on the age of onset, Batten disease usu-
ally leads to premature death when the patient is in his
or her late teens or early twenties;
VerDate Sep 11 2014
02:25 May 21, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR424.IH
HR424
pbinns on DSKJLVW7X2PROD with BILLS
2
•HRES 424 IH
Whereas Batten disease occurs in an estimated 2 to 4 of
every 100,000 births in the United States;
Whereas due to the many different forms of the disease,
there is significant variability in the age of onset and
symptom progression for each case;
Whereas on average, the process to reach the correct diag-
nosis for a patient with a rare disease could take up to
7.6 years, visits with numerous physicians, and multiple
misdiagnoses;
Whereas there is no known cure for Batten disease, and the
lack of essential funding has hindered scientists’ ability
to find a potential treatment or cure; and
Whereas the Federal Government has not done enough to
provide funding for rare diseases, and 95 percent of the
7,000 rare diseases still have no FDA-approved treat-
ment: Now, therefore, be it
Resolved, That the House of Representatives—
1
(1) supports the designation of a ‘‘Batten Dis-
2
ease Awareness Day’’; and
3
(2) calls for more funding for research to be
4
done on potential treatment and cures for rare dis-
5
eases.
6
Æ
VerDate Sep 11 2014
02:25 May 21, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\HR424.IH
HR424
pbinns on DSKJLVW7X2PROD with BILLS